The markets opened higher with the Dow gaining 36 points to 19,888 as crude oil prices edged up. Nasdaq added 5 points to 5,462.
On the upside
Evoke Pharma (Nasdaq: EVOK) received positive guidance from a pre-New Drug Application meeting with the Food and Drug Administration for Gimoti.
First quarter earnings for Jabil Circuit (NYSE: JBL) beat expectations.
Shares of DryShips (Nasdaq: DRYS) extended its gains.
On the downside
RXi Pharmaceuticals (Nasdaq: RXII) priced its public offering of securities at a discount.
Agios Pharmaceuticals (Nasdaq: AGIO) withdrew its investigational new drug application for AG-519 and will no longer develop its second pyruvate kinase-R activator.
Vehicle (Nasdaq: VCEL) priced its public offering of 6.2 million shares of common stock at the discounted price of $2.75 per share.
In the broad market, advancing issues outpaced decliners by a margin of 2 to 1 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index added 2 points to 2,264. Bitcoin rose $4 to $776.
